SCHEMBL441520

SCHEMBL441520

O=C1CCC=C2c3ccccc3NC12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
LMNA P02545 1/20 0.37
TNKS2 Q9H2K2 6/20 0.36
ALDH1A1 P00352 6/20 0.33
HSD17B10 Q99714 4/20 0.33
HPGD P15428 4/20 0.33
GAA P10253 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
PDGFRA P16234 1/20 0.33
FER P16591 1/20 0.33
LTK P29376 1/20 0.33
CDK8 P49336 1/20 0.33
ACVR1 Q04771 1/20 0.33
LRRK2 Q5S007 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
KDM4E B2RXH2 4/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5478810 0.77 CRBN (0.36) TSHRLMNAALDH1A1HSD17B10HPGD
SCHEMBL14746060 0.67 NOS2 (0.35) TSHRLMNATNKS2GAA
SCHEMBL2359522 0.66 LMNA (0.38) TSHRLMNAALDH1A1HSD17B10HPGD
SCHEMBL2233981 0.64 TSHR (0.37) TSHRLMNATNKS2ALDH1A1HSD17B10
SCHEMBL20159058 0.63 TSHR (0.36) TSHRLMNATNKS2ALDH1A1HSD17B10
SCHEMBL14785765 0.62 TNKS2 (0.53) TSHRLMNATNKS2ALDH1A1HSD17B10
SCHEMBL19183043 0.60 TNKS2 (0.42) TSHRLMNATNKS2ALDH1A1HSD17B10
SCHEMBL261677 0.59 LMNA (0.35) TSHRLMNATNKS2ALDH1A1HSD17B10
SCHEMBL19568178 0.59 TSHR (0.50) TSHRLMNATNKS2ALDH1A1HSD17B10
SCHEMBL6557130 0.59 TSHR (0.50) TSHRLMNATNKS2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745870-B Ondansetron intermediate of agar Synthesis method of tetrahydrocarbazolone 常州兰陵制药有限公司 2025-02-14 CN claimed
CN-118666733-A Application of tetrahydrocarbazole micromolecule compounds in preparation of antiviral drugs and preparation method thereof 中国人民解放军空军军医大学 2024-09-20 CN claimed
CN-115677559-B One-step synthesis method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2024-04-16 CN claimed
CN-114634442-B Preparation method of tetrahydrocarbazolone compound 内蒙古民族大学 2023-10-13 CN claimed
CN-115745870-A Synthetic method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2023-03-07 CN claimed
CN-115677559-A One-step synthesis method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2023-02-03 CN claimed
CN-114634442-A Preparation method of tetrahydrocarbazolone compound 内蒙古民族大学 2022-06-17 CN claimed
CN-110003187-B Polyfluoroalkyl substituted benzofuran compound and preparation method thereof 南京工业大学 2021-11-05 CN claimed
CN-107298640-B Preparation method and application of methylene ketone compound 曲阜师范大学 2020-08-04 CN claimed
CN-110105812-A A kind of no ink ink-jet ink and its preparation method and application 重庆理工大学 2019-08-09 CN claimed
EP-0934309-A1 NEW PYRIDYL ALKANE ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES Klinge Pharma GmbH (DE) 1999-08-11 EP claimed
EP-0923570-A1 PYRIDYL ALKENE- AND PYRIDYL ALKINE- ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES Klinge Pharma GmbH (DE) 1999-06-23 EP claimed
EP-0912176-A1 USE OF PYRIDYL ALKANE, PYRIDYL ALKENE AND/OR PYRIDYL ALKINE ACID AMIDES IN THE TREATMENT OF TUMORS OR FOR IMMUNOSUPPRESSION Klinge Pharma GmbH (DE) 1999-05-06 EP claimed
WO-1997048397-A1 USE OF PYRIDYL ALKANE, PYRIDYL ALKENE AND/OR PYRIDYL ALKINE ACID AMIDES IN THE TREATMENT OF TUMORS OR FOR IMMUNOSUPPRESSION KLINGE PHARMA GMBH (DE) 1997-12-24 WO claimed
WO-1997048696-A1 PYRIDYL ALKENE- AND PYRIDYL ALKINE- ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES KLINGE PHARMA GMBH (DE) 1997-12-24 WO claimed
WO-1997048695-A1 NEW PYRIDYL ALKANE ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES KLINGE PHARMA GMBH (DE) 1997-12-24 WO claimed
CN-1113913-A Preparing method for 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl-1H-imidazo-1-lyl)methyl]-4H-carbazole-4-ketone and its salts QILU PHARMACEUTICAL FACTORY (CN) 1995-12-27 CN claimed
US-5411968-A 5-hydroxytryptamine antagonists GLAXO GROUP LIMITED (GB) 1995-05-02 US claimed
EP-0229444-A2 Medicaments for the treatment of anxiety GLAXO GROUP LIMITED (GB) 1987-07-22 EP claimed
EP-0028270-A1 Pyrazino-carbazoles, process for their preparation and pharmaceutical compositions containing them CASSELLA Aktiengesellschaft (DE) 1981-05-13 EP claimed